PILASTER
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)
clinical trial
Source: Wikidata
← Back to UnAcronym1
Results for
PILASTER
1 result
Exact matches
Direct matches for the acronym you searched.
General